We are live on ! Find out more
TIL icon

Instil Bio
TIL

64 hedge funds and large institutions have $1.28B invested in Instil Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

3% more funds holding

Funds holding: 62 → 64 (+2)

0.06% more ownership

Funds ownership: 2.74% → 2.79% (+0.06%)

5% less capital invested

Capital invested by funds: $1.35B → $1.28B (-$61.6M)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
64
Holders Change
+2
Holders Change %
+3.23%
% of All Funds
1.12%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
9
Increased
18
Reduced
16
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.7M
2
ACH
ArrowMark Colorado Holdings
Colorado
+$2.38M
3
BPA
Beacon Pointe Advisors
California
+$1.83M
4
E
Ergoteles
New York
+$1.49M
5
PM
Parametrica Management
Hong Kong
+$863K

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$7.83M
2
NIP
Nicholas Investment Partners
California
-$3.24M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.08M
4
Morgan Stanley
Morgan Stanley
New York
-$930K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$820K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.27M +$166K +444 +8%
Charles Schwab
27
Charles Schwab
California
$2.17M +$51.1K +137 +2%
QF
28
QVT Financial
New York
$1.76M – – –
BPA
29
Beacon Pointe Advisors
California
$1.75M +$1.83M +4,890 New
VIA
30
Vident Investment Advisory
Georgia
$1.56M -$116K -311 -7%
E
31
Ergoteles
New York
$1.43M +$1.49M +3,996 New
HS
32
HighVista Strategies
Massachusetts
$1.29M +$572K +1,532 +74%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$1.26M +$176K +472 +15%
N
34
Nuveen
North Carolina
$1.13M -$22.8K -61 -2%
PM
35
Parametrica Management
Hong Kong
$826K +$863K +2,311 New
PPA
36
Parametric Portfolio Associates
Washington
$717K +$245K +655 +49%
Balyasny Asset Management
37
Balyasny Asset Management
Illinois
$472K +$492K +1,319 New
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$404K +$93.7K +251 +29%
Victory Capital Management
39
Victory Capital Management
Texas
$397K +$98.6K +264 +31%
CF
40
CNA Financial
Illinois
$390K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$305K +$18.7K +50 +6%
Norges Bank
42
Norges Bank
Norway
$268K – – –
M&T Bank
43
M&T Bank
New York
$245K +$256K +685 New
Stifel Financial
44
Stifel Financial
Missouri
$206K +$215K +575 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$193K -$8.96K -24 -4%
Goldman Sachs
46
Goldman Sachs
New York
$191K +$199K +533 New
JP Morgan Chase
47
JP Morgan Chase
New York
$186K -$1.49K -4 -0.8%
Deutsche Bank
48
Deutsche Bank
Germany
$183K -$1.49K -4 -0.8%
ACM
49
ACT Capital Management
Pennsylvania
$179K – – –
AIG
50
American International Group
New York
$175K – – –
1
2
3

TIL Hedge Fund Activity: Q3 2021 in Review

64 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q3 2021, worth a combined $1.28B — down 4.6% from $1.35B a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TIL positions and 7 closed out — a net gain of 2 holders — while 18 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.7M. The largest seller was Logos Global Management, cutting an estimated $7.83M.

  • 64 institutional investors held Instil Bio (TIL) as of Q3 2021, up from 62 in Q2 2021.
  • Funds reported $1.28B of Instil Bio stock for Q3 2021, down 4.6% quarter-over-quarter.
  • 9 funds opened new Instil Bio positions in Q3 2021 and 7 closed out, a net change of +2 holders.
  • The largest Instil Bio buyer in Q3 2021 was Fidelity Investments, an estimated $31.7M added.
  • The largest Instil Bio seller in Q3 2021 was Logos Global Management, an estimated $7.83M sold.

Based on aggregated 13F filings for Q3 2021.